Alyeska Investment Group, L.P.

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,492,849

-$1,748,130 QoQ

Shares Held

438,882

-5.3% QoQ

Ownership

1.40%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 143 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. LENZ ranks #61 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,492,849	438,882	-5.3%	Shares	Sole	2026-08-14
2026-03-31	$4,240,979	463,495	0.0%	Shares	Sole	2026-05-15
2025-12-31	$7,415,920	463,495	+91.4%	Shares	Sole	2026-02-13
2025-09-30	$11,277,623	242,113	+11.5%	Shares	Sole	2025-11-17
2025-06-30	$6,363,582	217,113	+52.8%	Shares	Sole	2025-08-14
2025-03-31	$3,653,725	142,113	0.0%	Shares	Sole	2025-05-15
2024-12-31	$4,102,802	142,113	+16.4%	Shares	Sole	2025-02-14
2024-09-30	$2,898,962	122,113	-62.0%	Shares	Sole	2024-11-14
2024-06-30	$5,562,452	321,715	+61.2%	Shares	Sole	2024-08-14
2024-03-31	$4,457,112	199,602	—	Shares	Sole	2024-05-15
2021-06-30 GRPH	—	30,000	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.